Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NextBio Life Science Search Engine Licensed by the Burnham Institute to Speed Research Across Public and Private Data

Published: Tuesday, February 05, 2008
Last Updated: Tuesday, February 05, 2008
Bookmark and Share
Under the agreement, every scientist at the Burnham Institute will gain access to the NextBio life science search engine.

NextBio has announced that it has renewed and expanded its licensing agreement with the Burnham Institute for Medical Research in San Diego, California, for the use of NextBio’s life science search engine.

Under the agreement, every scientist at the Burnham Institute will gain access to the NextBio life science search engine, enabling them to search data from both public and proprietary sources to bring their own experimental results within the context of other research findings worldwide.

“In one of our key studies, we used the NextBio search engine to interpret the gene expression changes between adenoma tumors associated with two distinct genotypes,” said Robert Oshima, Ph.D., Tumor Development Program co-Director and Professor at the Burnham Institute.

“Instead of manually evaluating hundreds of genes through literature, we were able to quickly search for conditions with similar biological changes using a combined collection of public studies. NextBio has proven to be valuable in interpreting gene expression changes in our experiments.”

“The ability of Burnham scientists to utilize huge quantities of public and internal experimental data in an easy way is fundamental to our research efforts," commented Craig Hauser, Ph.D., Cancer Center Associate Director at Burnham Institute for Medical Research. "NextBio’s life science search engine enables our researchers and clinicians to generate and validate new hypotheses using information from thousands of large-scale experimental studies.”

“We are delighted to see the Burnham Institute provide access to NextBio for its entire research staff and believe that NextBio will become an integral part of their daily research,” said Ilya Kupershmidt, NextBio’s Vice President of Product Management. ”We are very pleased that Burnham, as one of our pioneering customers, has renewed and expanded its license to use NextBio.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Creating Ideal Neural Cells for Clinical Use
New protocol differentiates human embryonic stem cells into committed neural precursor cells.
Tuesday, April 21, 2009
Creating Ideal Neural Cells for Clinical Use
New protocol differentiates human embryonic stem cells into committed neural precursor cells.
Tuesday, April 14, 2009
Mechanism by which Signaling Pathways Regulate Growth and Differentiation of Adult Muscle Stem Cells Revealed
Researchers shows how two signaling pathways work together to assemble components of the protein complexes responsible for muscle-specific transcription.
Thursday, December 13, 2007
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!